Correlation Between Pharmaceuticals Ultrasector and Goldman Sachs
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Goldman Sachs Technology, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Goldman Sachs.
Diversification Opportunities for Pharmaceuticals Ultrasector and Goldman Sachs
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pharmaceuticals and Goldman is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Goldman Sachs Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Technology and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Technology has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Goldman Sachs go up and down completely randomly.
Pair Corralation between Pharmaceuticals Ultrasector and Goldman Sachs
Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 1.8 times more return on investment than Goldman Sachs. However, Pharmaceuticals Ultrasector is 1.8 times more volatile than Goldman Sachs Technology. It trades about 0.22 of its potential returns per unit of risk. Goldman Sachs Technology is currently generating about 0.21 per unit of risk. If you would invest 2,129 in Pharmaceuticals Ultrasector Profund on May 22, 2025 and sell it today you would earn a total of 513.00 from holding Pharmaceuticals Ultrasector Profund or generate 24.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharmaceuticals Ultrasector Pr vs. Goldman Sachs Technology
Performance |
| Timeline |
| Pharmaceuticals Ultrasector |
| Goldman Sachs Technology |
Pharmaceuticals Ultrasector and Goldman Sachs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharmaceuticals Ultrasector and Goldman Sachs
The main advantage of trading using opposite Pharmaceuticals Ultrasector and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.| Pharmaceuticals Ultrasector vs. Fbanjx | Pharmaceuticals Ultrasector vs. Fdzbpx | Pharmaceuticals Ultrasector vs. Ab Value Fund | Pharmaceuticals Ultrasector vs. Balanced Fund Retail |
| Goldman Sachs vs. Yuanbao American Depositary | Goldman Sachs vs. Viewbix Common Stock | Goldman Sachs vs. Datavault AI | Goldman Sachs vs. VivoPower International PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |